Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study [Intervento farmacologico nelle tecniche di procreazione in vitro: studio prospettico randomizzato sull' utilizzo di profilassi con eparina a basso peso molecolare per la riduzione del rischio di fallimento di impianto]

Trial Profile

Effect of pharmacological prophylaxis with low molecular weight heparin on implantation in women undergoing assisted reproductive procedures to prevent implant failure: a prospective randomized study [Intervento farmacologico nelle tecniche di procreazione in vitro: studio prospettico randomizzato sull' utilizzo di profilassi con eparina a basso peso molecolare per la riduzione del rischio di fallimento di impianto]

Recruiting
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Dalteparin sodium (Primary)
  • Indications Female infertility; Thrombosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top